早在1995年的AHA第5次预防会议上,就提出了炎症标志物的检测对识别需要给予一级预防的冠心病高危人群的作用。近来许多研究表明[1～7],稳定型冠心病或ACS患者,其C-反应蛋白(CRP)可用作预告再发心脏事件的独立危险因子,目前这些患者首选的药物治疗是肝素抗凝。2003年7月～2004年 As early as the 1995 AHA Fifth Prevention Conference, the proposed detection of inflammatory markers on the identification of need for primary prevention of coronary heart disease in high-risk groups role. Recently, many studies have shown that [1-7], stable coronary heart disease or ACS patients, its C-reactive protein (CRP) can be used as an independent risk factor for the prediction of recurrence of cardiac events, the current choice of drugs in these patients is heparin anticoagulant . July 2003 ~ 2004 years